MEF2A Promotes Keratinocyte Proliferation and Migration Under High‐Glucose Conditions via Activation of the PI3K/AKT Signaling Pathway: Implications for Diabetic Wound Healing
The Journal of Gene Medicine · 2026-11 · 28 (11)
DOI: 10.1002/jgm.70120 ↗Abstract
ABSTRACT Delayed wound healing, a serious complication of diabetes, remains a clinical challenge. Myocyte enhancer factor 2A (MEF2A) functions in muscle‐specific and/or growth factor‐related transcription and is involved in cell growth, survival, and apoptosis. To evaluate the role of this transcription factor in keratinocytes during the diabetic wound healing process, we conducted a series of in vivo and in vitro experiments. We found that MEF2A expression was upregulated in skin wound tissues of a spontaneous type 2 diabetic db/db mouse model. Similarly, MEF2A was highly expressed in human keratinocytes (HaCaT) under high glucose (HG) conditions. In HaCaT cells, overexpression of MEF2A enhanced cell proliferation and migration under HG conditions and also effectively attenuated HG‐induced apoptosis, as evidenced by the upregulated anti‐apoptotic protein Bcl‐2 and the downregulated pro‐apoptotic protein Bax and caspase‐3 activity. Additionally, overexpression of MEF2A increased the phosphorylation level of AKT in HaCaT cells. However, treatment with the PI3K/AKT pathway inhibitor LY294002 reversed the beneficial effect of MEF2A on HaCaT proliferation and migration. Our study suggests that overexpression of MEF2A can activate the PI3K/AKT signaling pathway by enhancing the phosphorylation level of the Ser473 site of AKT protein in HaCaT cells, thereby regulating the proliferation and migration of HaCaT cells under HG conditions. This provides a potential therapeutic target for diabetic wound healing.
EUVIMED